DFCI @ Foxborough — Foxborough, Massachusetts

DFCI @ Foxborough is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

DFCI @ Foxborough has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.

Sponsors: Dana-Farber Cancer Institute, Ana C Garrido-Castro, MD.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Foxborough

Browse all research sites in Massachusetts · View every site in Foxborough

• Dana-Farber Cancer Institute at Foxborough
• Neurology Center of New England P.C.
• Neurology Center of New England
• Dana-Farber Brigham Cancer Center Foxborough
• Neurology Center of New England PC
• K2 Medical Research - Foxborough
• Dana-Farber Cancer Institute @Foxborough
• Neurology Center of NE,PC - Neurology
• Research Site
• Neuro Institute of New England P C
• Brigham and Women's-Mass General Health Care Center

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DFCI @ Foxborough?

DFCI @ Foxborough has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DFCI @ Foxborough conducted?

DFCI @ Foxborough has 3 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative.

Is DFCI @ Foxborough accredited by Crixeo Clinical Trials?

DFCI @ Foxborough has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DFCI @ Foxborough?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.